Eternatear INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersRaleigh, NC
US patents5
SAM.gov UEIP8ZRP8ARGQD5
CAGE code10ST7
Incorporated inDE
- tears
- dry eye
- proven technologies
- pioneering research
- tear film
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
5 US patents granted 2022–2024, 5 of them in the five years to SEP 2025.
Pharmaceuticals 5
- Ophthalmic formulations and related methodsUS 12,005,139 · granted JUN 11, 2024
- Ophthalmic formulations and related methodsUS 11,964,047 · granted APR 23, 2024
- Ophthalmic formulations and related methodsUS 11,679,079 · granted JUN 20, 2023
- Ophthalmic formulations and related methodsUS 11,679,078 · granted JUN 20, 2023
- Ophthalmic formulations providing durable ocular lubricationUS 11,278,493 · granted MAR 22, 2022
Granted to Eternatear, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Eternatear INC | Raleigh | NC | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.